Solid Biosciences, a publicly traded life science company focused solely on creating therapies for treating Duchenne muscular dystrophy, signed a 10-year lease for just under 50,000 square feet of office, laboratory, research and development and manufacturing space at 500 Rutherford Ave. in Charlestown, Massachusetts.
Life Science Firm Takes Office-Lab Space in Charlestown's Hood Park
Solid Biosciences Signs New 10-Year Lease at 500 Rutherford Ave.
RELATED ARTICLES
This news story is available exclusively to CoStar subscribers.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In
IN THIS ARTICLE
- Properties